Syringomatous Tumor of the Nipple.

World J Oncol

Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

Published: August 2022

Syringomatous tumor of the nipple (SyT), previously known as syringomatous adenoma of the nipple (SAN) was originally described in 1983 as a rare benign tumor of the sweat duct. It is a rare benign tumor arising from the skin adnexal eccrine glands that can be misdiagnosed as invasive carcinoma due to its infiltrative nature, resulting in overtreatment. We report clinical, histopathologic, and surgical findings of a case of infiltrating syringomatous adenoma in a 40-year-old female as well as a literature review of previous cases. A high index of suspicion is required to make the diagnosis of SyT and prevent overtreatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451573PMC
http://dx.doi.org/10.14740/wjon1513DOI Listing

Publication Analysis

Top Keywords

syringomatous tumor
8
tumor nipple
8
syringomatous adenoma
8
rare benign
8
benign tumor
8
syringomatous
4
nipple syringomatous
4
nipple syt
4
syt syringomatous
4
adenoma nipple
4

Similar Publications

A fusion between tubulin polymerization-promoting protein (TPPP), a regulatory cytoskeletal gene, and the chromatin remodeling factor, bromodomain-containing protein 9 (BRD9), TPPP-BRD9 fusion has been found in rare cancer cases, including lung and gallbladder cancers (GBC). In this study, we investigated the histopathological features of 16 GBCs previously shown by RNA sequencing to harbor the TPPP-BRD9 fusion. Findings in the fusion-positive GBCs were compared with 645 GBC cases from the authors' database.

View Article and Find Full Text PDF
Article Synopsis
  • * A case study is highlighted where a 33-year-old woman discovered a nodule in her left areolar region four years prior, but surgery for removal wasn't performed until after a breast lift two years later, when the tumor was finally identified.
  • * The histopathology of the removed tissue showed the syringomatous tumor had positive margins, but as of 13 months post-diagnosis, the patient is doing well and is under clinical follow-up.
View Article and Find Full Text PDF

Multimodality Imaging of Benign and Malignant Diseases of the Nipple-Areolar Complex.

Radiographics

April 2024

From the Departments of Breast Imaging (M.S.G., E.M.A., M.M.K., M.M.P., F.P., E.S.N., T.W.M., B.E.A.), Pathology-Anatomical (Q.D.), and Breast Surgical Oncology (T.W.M.), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1350, Houston, TX 77030.

Article Synopsis
  • - The nipple-areolar complex (NAC) is a crucial part of breast anatomy that can be affected by various benign and malignant diseases, often presenting overlapping symptoms and imaging findings.
  • - Understanding NAC's unique structure and the various conditions affecting it is key for accurate diagnosis; this includes assessing nipple discharge, which can signal serious issues like breast cancer.
  • - A multimodal imaging approach, particularly utilizing breast MRI alongside other techniques, is essential for evaluating NAC diseases and guiding appropriate clinical management, including biopsy options for testing identified issues.
View Article and Find Full Text PDF
Article Synopsis
  • - Syringoid eccrine carcinoma (SEC) is a rare and aggressive skin cancer that typically appears as nodules or plaques, often in the head, neck, or trunk, making it challenging to diagnose due to its varied appearance.
  • - The cancer exhibits unique growth patterns characterized by infiltrative behavior and potential to spread, with histological features resembling syringomas and showing ductular differentiation.
  • - This text discusses a rare case of SEC found in the nipple of a 51-year-old male, marking only the second documented instance of this condition in a male patient, and it was complicated by metastasis to the axillary lymph nodes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!